naproxen
NDC 69097-853, naproxen, tablet, from Cipla USA Inc..
- Product NDC
- 69097-853
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091305
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-853 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN250 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-853-07 | 69097085307 | 100 TABLET in 1 BOTTLE (69097-853-07) |
| 69097-853-12 | 69097085312 | 500 TABLET in 1 BOTTLE (69097-853-12) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a9549a47-3fa4-4a2b-95ac-b00e43aedae7
Use it
Look up 69097-853 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-853 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-853. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.